Literature DB >> 22491066

Interferon signatures in immune disorders and disease.

Samuel Forster1.   

Abstract

The interferon (IFN) family and the type-I IFNs specifically have an important and well-characterized role in antiviral defence, immune modulation and cell-cycle control and are regularly applied in the clinical context. Advances in high-content technologies have facilitated an enhanced understanding of the global IFN response capable of being induced. Recent application of these technologies is improving our understanding of the specificity and subtleties associated with this response. This review considers our current understanding of the temporal gene profile induced through IFN stimulation across a diversity of disease conditions including autoimmune diseases, bacterial and viral infections. Understanding these signatures, the disease-specific differences and the biological effects induced has the potential to facilitate IFN-driven therapeutic development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491066     DOI: 10.1038/icb.2012.12

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  17 in total

1.  Beyond EMT: Epithelial STAT3 as a Central Regulator of Fibrogenesis.

Authors:  Jeremy S Duffield
Journal:  J Am Soc Nephrol       Date:  2016-07-01       Impact factor: 10.121

2.  A panel of synthetic antibodies that selectively recognize and antagonize members of the interferon alpha family.

Authors:  S Miersch; S Kuruganti; M R Walter; S S Sidhu
Journal:  Protein Eng Des Sel       Date:  2017-09-01       Impact factor: 1.650

3.  The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation.

Authors:  Mandar Bawadekar; Marco De Andrea; Irene Lo Cigno; Gianluca Baldanzi; Valeria Caneparo; Andrea Graziani; Santo Landolfo; Marisa Gariglio
Journal:  J Interferon Cytokine Res       Date:  2015-02-25       Impact factor: 2.607

4.  Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Authors:  Magar Ghazarian; Xavier S Revelo; Mark K Nøhr; Helen Luck; Kejing Zeng; Helena Lei; Sue Tsai; Stephanie A Schroer; Yoo Jin Park; Melissa Hui Yen Chng; Lei Shen; June Ann D'Angelo; Peter Horton; William C Chapman; Diane Brockmeier; Minna Woo; Edgar G Engleman; Oyedele Adeyi; Naoto Hirano; Tianru Jin; Adam J Gehring; Shawn Winer; Daniel A Winer
Journal:  Sci Immunol       Date:  2017-04-21

5.  Type I Interferons Act Directly on Nociceptors to Produce Pain Sensitization: Implications for Viral Infection-Induced Pain.

Authors:  Paulino Barragán-Iglesias; Úrzula Franco-Enzástiga; Vivekanand Jeevakumar; Stephanie Shiers; Andi Wangzhou; Vinicio Granados-Soto; Zachary T Campbell; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2020-04-03       Impact factor: 6.167

6.  Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity.

Authors:  Ling Wang; Juan Zhao; Junping Ren; Kenton H Hall; Jonathan P Moorman; Zhi Q Yao; Shunbin Ning
Journal:  Eur J Immunol       Date:  2016-08-29       Impact factor: 5.532

Review 7.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

8.  Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.

Authors:  Dewan Md Sakib Hossain; Sarah Javaid; Mingmei Cai; Chunsheng Zhang; Anandi Sawant; Marlene Hinton; Manjiri Sathe; Jeff Grein; Wendy Blumenschein; Elaine M Pinheiro; Alissa Chackerian
Journal:  J Clin Invest       Date:  2018-01-16       Impact factor: 14.808

9.  Parsing the Interferon Transcriptional Network and Its Disease Associations.

Authors:  Sara Mostafavi; Hideyuki Yoshida; Devapregasan Moodley; Hugo LeBoité; Katherine Rothamel; Towfique Raj; Chun Jimmie Ye; Nicolas Chevrier; Shen-Ying Zhang; Ting Feng; Mark Lee; Jean-Laurent Casanova; James D Clark; Martin Hegen; Jean-Baptiste Telliez; Nir Hacohen; Philip L De Jager; Aviv Regev; Diane Mathis; Christophe Benoist
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

Review 10.  Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS.

Authors:  Ulrich Kalinke; Marco Prinz
Journal:  Immunol Cell Biol       Date:  2012-03-20       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.